Annual CAPEX
N/A
31 December 2023
Summary:
Esperion Therapeutics annual capital expenditures is not available.ESPR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$167.00 K
+$90.00 K+116.88%
30 September 2024
Summary:
Esperion Therapeutics quarterly capital expenditures is currently $167.00 thousand, with the most recent change of +$90.00 thousand (+116.88%) on 30 September 2024. ESPR quarterly CAPEX is now -98.68% below its all-time high of $12.68 million, reached on 31 December 2020.ESPR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$317.00 K
+$167.00 K+111.33%
30 September 2024
Summary:
Esperion Therapeutics TTM capital expenditures is currently $317.00 thousand, with the most recent change of +$167.00 thousand (+111.33%) on 30 September 2024. ESPR TTM CAPEX is now -97.63% below its all-time high of $13.37 million, reached on 31 December 2020.ESPR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | -53.4% | -59.4% |
ESPR CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +128.8% | at high | +334.3% | ||
| 5 y | 5 years | -98.7% | +301.2% | -97.6% | +334.3% | ||
| alltime | all time | -98.7% | +301.2% | -97.6% | +334.3% |
Esperion Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $167.00 K(+116.9%) | $317.00 K(+111.3%) |
| June 2024 | - | $77.00 K(+5.5%) | $150.00 K(+105.5%) |
| Mar 2024 | - | $73.00 K(-99.4%) | $73.00 K(-99.5%) |
| Dec 2020 | $13.37 M(+1302.8%) | $12.68 M(<-9900.0%) | $13.37 M(+1445.5%) |
| Sept 2020 | - | -$83.00 K(-114.2%) | $865.00 K(-33.8%) |
| June 2020 | - | $585.00 K(+206.3%) | $1.31 M(+36.8%) |
| Mar 2020 | - | $191.00 K(+11.0%) | $955.00 K(+0.2%) |
| Dec 2019 | $953.00 K(+531.1%) | $172.00 K(-52.0%) | $953.00 K(+22.0%) |
| Sept 2019 | - | $358.00 K(+53.0%) | $781.00 K(+84.6%) |
| June 2019 | - | $234.00 K(+23.8%) | $423.00 K(+123.8%) |
| Mar 2019 | - | $189.00 K | $189.00 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $151.00 K(+694.7%) | - | - |
| Dec 2017 | $19.00 K(-79.8%) | - | - |
| Dec 2016 | $94.00 K(-71.1%) | - | - |
| Dec 2015 | $325.00 K(-62.8%) | - | - |
| Dec 2014 | $873.00 K(+2716.1%) | - | - |
| Dec 2013 | $31.00 K(+342.9%) | - | - |
| Dec 2012 | $7000.00(-79.2%) | - | - |
| Dec 2011 | $33.60 K(-97.1%) | - | - |
| Dec 2002 | $1.16 M(-42.9%) | - | - |
| Dec 2001 | $2.02 M(+50.9%) | - | - |
| Dec 2000 | $1.34 M(-14.2%) | - | - |
| Dec 1999 | $1.56 M | - | - |
FAQ
- What is the all time high annual CAPEX for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Esperion Therapeutics?
- What is Esperion Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Esperion Therapeutics?
What is the all time high annual CAPEX for Esperion Therapeutics?
Esperion Therapeutics all-time high annual capital expenditures is $13.37 M
What is Esperion Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of ESPR is $167.00 K
What is the all time high quarterly CAPEX for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly capital expenditures is $12.68 M
What is Esperion Therapeutics TTM capital expenditures?
The current TTM CAPEX of ESPR is $317.00 K
What is the all time high TTM CAPEX for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM capital expenditures is $13.37 M